{
    "nctId": "NCT02426944",
    "officialTitle": "Interventional Left Atrial Appendage Closure vs. Novel Anticoagulation Agents in High-risk Patients With Atrial Fibrillation (PRAGUE-17 Study)",
    "inclusionCriteria": "1. history of significant bleeding (i.e. bleeding which required intervention or hospitalization), even in the absence of anticoagulation treatment at the time of the bleeding event, or\n2. a cardioembolic event, which occurred on anticoagulation, or\n3. a high risk profile of the patient, defined as a CHA2DS2-VASc score \u2265 3 and a HAS-BLED score \u2265 2\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "1. thrombus in the LA or LAA;\n2. mechanical valve prosthesis;\n3. mitral stenosis;\n4. previous LAA ligation during cardiac surgery;\n5. life expectancy less than 2 years;\n6. comorbidities other than AF, which present an indication for anticoagulation;\n7. patent foramen ovale with atrial septal aneurysm\n8. mobile plaque in the aorta;\n9. symptomatic atherosclerosis of the carotid artery;\n10. pericardial effusion greater than 10 mm;\n11. clinically significant bleeding within the 30 days prior to the scheduled procedure;\n12. stroke or other cardioembolic event within the 30 days prior to the scheduled procedure;\n13. acute coronary syndrome within the 90 days prior to the scheduled procedure,\n14. gravidity,\n15. significant valvular disease,\n16. creatinine clearance less than 30 ml/min"
}